Appropriateness of the use of physical restraints and psychotropic medication in institutionalised older people: Comparative study in Quebec and French Switzerland. Applicability to Spain;Adecuación de las restricciones físicas y farmacológicas en los ancianos institucionalizados: Estudio comparativo en Québec y la Suiza Romanda, con implicaciones en nuestro medio

Revista Espanola de Geriatria y Gerontologia

Volumn 40, Issue 1, 2005, Pages 7-17

  Gobert, M ^a   D'Hoore, W ^a   Mora Fernandez J ^b   Moldes Rodriguez M P ^c   Tilquin, C ^d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Residencia de Ancianos Pablo Neruda   (Spain)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Appropriateness; Comparative study; Physical and pharmacological restriction methods; Quebec; Romande Switzerland

Indexed keywords

BROMAZEPAM; CHLORAL HYDRATE; CITALOPRAM; CLOMETHIAZOLE; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; MIANSERIN; MIDAZOLAM; OXAZEPAM; PAROXETINE; PIPAMPERONE; PSYCHOTROPIC AGENT; THIORIDAZINE; ZOLPIDEM; ZUCLOPENTHIXOL;

AGED; ARTICLE; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DATA ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INSTITUTIONALIZATION; LOGISTIC REGRESSION ANALYSIS; MALE; PREVALENCE; PSYCHOSIS; QUALITY CONTROL; RESEARCH; RESOURCE ALLOCATION; SPAIN; SWITZERLAND; UTILIZATION REVIEW;

EID: 14844291304     PISSN: 0211139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0211-139x(05)74817-4     Document Type: Article

References (57)

1. OBRA (Omnibus Budget Reconciliation Act] 1987. US Congress. Public Law 101-508.
2. AGS Position Statement. Guidelines for Restraint Use. The American Geriatric Society 1997. Disponible en: http://www.americangeriatrics.org/ products/positionpapers/restrain.shtml
3. Schnelle JF, MacRae PG, Simmons SF, Ulman G, Ouslander JG, Rosenquist LL, et al. Safety assessment for the frail elderly: a comparison of restrained and unrestrained nursing home residents. J Am Geriatr Soc. 1994;42:586-92.
4. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health. 1980;70:485-91.
5. Bravo G, De Wals P, Dubois MF, Charpentier M. Correlates of care quality in long-term care facilities: a multilevel analysis. J Gerontol Psychol Sci. 1999;54B:180-8.
6. Graber DR, Sloane PD. Nursing home survey deficiencies for physical restraint use. Med Care. 1995;33:1051-63.
7. Harvey RJ. A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease, Int J Geriatr Psychiatry. 1999;14:249-56.
8. Zimmerman DR, Karon SL, Arling G, Clark BR, Collins T, Ross R, et al. Development and testing of nursing home quality indicators. Health Care Financ Rev. 1995;16:107-27.
9. Tinetti ME, Liu WL, Marottoli RA, Ginter SF. Mechanical restraint use among residents of skilled nursing facilities. J Am Med Assoc. 1991;265:468-71.
10. Dube AH, Mitchell EK. Accidental strangulation from vest restraints. J Am Med Assoc. 1986;256:2725-6.
11. Maio VJ, Dana SE, Bux RC. Deaths caused by restraint vests. J Am Med Assoc. 1986;255:905.
12. Miles SH, Irvine P. Deaths caused by physical restraints. Gerontologist. 1992;32:762-6.
13. Tinetti ME, Liu WL, Ginter SF. Mechanical restraint use and fall-related injuries among residents of skilled nursing facilities. Ann Intern Med. 1992;116:369-74.
14. Ejaz FK, Jones JA, Rose MS. Falls among nursing home residents: an examination of incident reports before and after restraint reduction programs. J Am Geriatr Soc. 1994;42:960-4.
15. Williams CC, Finch CE. Physical restraint: no fit for woman, man, or beast. J Am Geriatr Soc. 1997;45:773-5.
16. Phillips CD, Hawes C, Mor V, Freis BE, Morris JN, Nennstiel ME. Facility and area variation affecting the use of physical restraints in nursing home. Med Care. 1996;34:1149-62.
17. Hughes CM, Lapone KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care. 2000;38:1164-73.
18. Sorensen L, Foldspang A, Gulmann NC, Munk-Jorgensen P. Determinants for the use of psychotropics among nursing home residents, Int J Geriatr Psychiatry. 2001;16:147-54.
19. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Int Med. 1991;151:1825-32.
20. Gorrard J, Makris L, Dunham T, Heston LL, Cooper S, Ratner ER, et al. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. J Am Med Assoc. 1991;265:463-7.
21. Rovner B, Edelman BA, Cox MP, et al. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry. 1992;149:1390-2.
22. Shorr RI, Fought RL, Way WA, et al. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. J Am Med Assoc. 1994;271:358-62.
23. Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc. 1994;42:648-52.
24. Castle NG, Mor V. Physical restraints in nursing homes: a review of the literature since the Nursing Home Reform Act of 1987. Med Care Res Rev. 1998;55:139-70.
25. Sloane PD, Mathew U, Scarborough M, Desai JR, Koch GG, Tanger C. Physical and pharmacologic restraint of nursing home patients with dementia. J Am Med Assoc. 1991;265:1278-82.
26. Sloane PD, Papougenis D, Blakeslee JA. Alternatives to physical and pharmacologic restraints in long-term care. Am Fam Physician. 1992;45:763-9.
27. Ljunggren G, Phillips CD, Sgadari A. Comparisons of restraint use in nursing homes in eight countries. Age Ageing. 1997;26 Suppl 2:43-7.
28. Karlsson S, Bucht G, Eriksson S, Sandman PO. Physical restraints in geriatric care in Sweden: prevalence and patient characteristics. J Am Geriatr Soc. 1996;44:1348-54.
29. Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol. 2001;57:523-8.
30. Alarcón Alarcón T. Uso de restricción física en el anciano en el siglo XXI. ¿Necesidad o folta de formacion? Rev Esp Geriatr Gerontol. 2001;36:46-50.
31. Boletín Oficial de la Comunidad de Madrid. Decreto 72/2001, de 31 de mayo, del Consejo de Gobierno, por el que se regula el régimen jurídico b́asico del Servicio Público de Atención a Personas Mayores en Residencias, Centros de Atención de Día y Pisos Tutelados. BOCM de 4 de junio de 2001. Disponible en: http://www.madrid. org/normativa_servicios_sociales/personas_mayores/D_%2072_2001a.html
32. Boletín Oficial de la Comunidad de Madrid. Orden 766/1993, de 10 de junio. Reglamento de Organización y Funcionamiento de las Residencias de Ancianos gestionadas por el Servicio Regional de Bienestar Social. BOCM de 21 de junio de 1993 (modificada por Orden 1009/1995 de 25 de mayo). Disponible en: http://www.madrid.org/normativa_servicios_sociales/personas_mayores/O_766_93. html
33. Phillips CD, Spry KM, Sloane PD, Hawes C. Use of physical restraints and psychotropic medications in Alzheimer special care units in nursing homes. Am J Public Health. 2000;90:92-6.
34. Siegler EL, Capezuti E, Maislin G, Baumgarten M, Evans L, Strumpf N. Effects of a restraint reduction intervention and OBRA'87 regulations on psychoactive drug use in nursing homes. J Am Geriatric Soc. 1997;45:791-6.
35. Borson S, Doane K. The impact of OBRA'87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv. 1997;48:1289-96.
36. Werner P, Koroknay V, Cohen-Mansfield J. Individualized care alternatives used in the process of removing physical restraints in the nursing home. J Am Geriatr Soc. 1994;42:321-5.
37. Bravo G, Charpentier M, Dubois MF, De Wals P, Emond A. Profile of residents in unlicensed homes for the aged in the Eastern Townships of Quebec. Can Med Assoc J. 1998;159:143-8.
38. Tilquin C, Roussel B. Systėme PLAISIR: manuel de référence. Montréal, Québec, Canada: EROS, Université de Montréal; 1993.
39. Harrington C, Tompkins C, Curtis M, Grant L. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist. 1992;32:822-33.
40. World Health Organization. Anatomical Therapeutic Chemical Classification Index with Defined Daily Doses. Oslo: WHO; 1999. p. 89.
41. Schnelle JF, Smith RL. To use physical restraints or not? J Am Geriatr Soc. 1996;44:727-8.
42. Hosmer DW, Lemeshow S, editors. Applied logistic regression. New York: Wiley; 1989. p. 308.
43. SPSS V 10.0. Statistical package for the Social Sciences.
44. Hughes CM, Lapane KL, Mor V, et al. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc. 2000;48:931-7.
45. Sullivan-Marx EM, Strumpf NE, Evans LK, Baumgarten M, Maislin G. Predictors of continued physical restraint use in nursing home residents following restraint reduction effects. J Am Geriatr Soc. 1999;47:342-8.
46. Karlsson S, Bucht G, Eriksson S, Sandman PO. Factors relating to the use of physical restraints in geriatric care settings. J Am Geriatr Soc. 2001;49:1722-8.
47. Góngora L, Puche E, García J, Luna JD. Prescripciones inapropiadas en ancianos institucionalizados. Rev Esp Geriatr Gerontol. 2004;39:19-24.
48. Lapane KL, Hughes CM. Optimising drug utilisation in long term care. Pharmacoeconomics. 2002;20:143-52.
49. Dunbar JM, Neufeld RR, White HC, Libow LS. Restrain, don't restrain: the educational intervention of the national nursing home restraint removal project. Gerontologist. 1996;36:539-42.
50. Ray WA. Improving quality of long term care. Med Care. 2000;38: 1151-3.
51. Sociedad Española de Enfermería Geriátrica y Gerontológica. Hacia una cultura sin restricciones: las restricciones físicas en ancianos institucionalizados. Documento técnico número 3. SEEGG 2003. Disponible en: http://www.arrakis.es/seegg/ Documentos%20tecnicos/3.htm
52. Hawes C, Morris JN, Phillips CD, Fries BE, Murphy K, Mor V. Development of the nursing home Resident Assessment Instrument in the USA. Age Ageing. 1997;26 Suppl 2:19-25.
53. De Santiago-Juárez Lopez JA, Zurro Hernández J, editores. Guía de criterios de calidad de centros sociales y sociosanitarios en regimen residencial para personas mayores: manual de acreditación. Madrid: Fundación Sanitas, Saned; 2002. p. 100.
54. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327:168-73.
55. Ray WA, Taylor JA, Meador KG, et al. Reducing antipsychotic drug use in nursing homes: a controlled trial of provider education. Arch Intern Med. 1993;153:713-21.
56. Evans LK, Strumpf EN, Allen-Taylor SL, Capezuti E, Maislin G, Jacobsen B. A clinical trial to reduce restraints in nursing homes. J Am Geriatr Soc. 1997;45:675-81.
57. Schmidt I, Claesson CB, Westerholm B, Nilson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77-82.